A Study To Evaluate The Safety And Efficacy Of An Investigational Diabetes Drug In Poorly Controlled Type II Diabetics
Status:
Completed
Trial end date:
2004-11-30
Target enrollment:
Participant gender:
Summary
The purpose of this research study is to determine if a new investigational diabetes drug is
safe and effective in treating people who have Type II diabetes mellitus with very high HbA1c
or FPG (fasting plasma glucose) levels. The HbA1c test, also called the hemoglobin A1c test
or glycated hemoglobin test, is a measurement of the average amount of sugar in the blood
over the last 2 to 3 months. FPG is a test that measures the amount of sugar in the blood
after an 8 hour fast.